Perspectives of the prevention of hepatitis B
Polz, M.A.
Polski Tygodnik Lekarski 38(36): 1111-1113
1983
ISSN/ISBN: 0032-3756 PMID: 6371729 Document Number: 207939
Document emailed within 1 workday
Related Documents
Stevens, C.E.; Taylor, P.E.; Tong, M.J.; Toy, P.T.; Vyas, G.N.; Nair, P.V.; Weissman, J.Y.; Krugman, S. 1987: Yeast-recombinant hepatitis B vaccine. Efficacy with hepatitis B immune globulin in prevention of perinatal hepatitis B virus transmission JAMA 257(19): 2612-2616Hu, Z.; Teng, H.; Han, M. 1994: Observation on prevention of hepatitis B virus transmission from mother to baby by hepatitis B vaccine Zhonghua Liu Xing Bing Xue Za Zhi 15(6): 346-348
Ito, S.; Takaoka, T.; Kajimoto, Y.; Muguruma, N.; Fukuda, T.; Okabe, T.; Horikita, M.; Hibino, S.; Hayashi, H.; Honda, H. 1991: Prevention of posttransfusional non-A, non-B hepatitis by a screening test for hepatitis C virus antibody of donor bloods Tokushima Journal of Experimental Medicine 38(1-2): 19-23
Li, R-cheng.; Yang, J-ye.; Gong, J.; Li, Y-ping.; Huang, Z-neng.; Fang, K-xiong.; Xu, Z-yi.; Liu, C-bai.; Zhao, K.; Zhuang, H. 2004: Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma Zhonghua Liu Xing Bing Xue Za Zhi 25(5): 385-387
Echevarría Mayo, Jé.M.; León Rega, P. 2003: Sreening of blood for antibody to hepatitis B virus core antigen and prevention of post-transfusional hepatitis C before 1990 Medicina Clinica 120(10): 397
Trépo, C. 2002: Hepatitis C: therapeutic perspectives Gastroenterologie Clinique et Biologique 26(Special Issue 2): B297-B302
McCreaddie, M. 2001: The hepatitis viruses. 2. Testing for hepatitis, treatment and prevention Nursing Times 97(48): 41-44
Kuhns, W.J.; Prince, A.M.; Brotman, B.; Hazzi, C.; Grady, G.F. 1976: A clinical and laboratory evaluation of immune serum globulin from donors with a history of hepatitis: attempted prevention of post-transfusion hepatitis American Journal of the Medical Sciences 272(3): 255-261
Nau, J.-Y. 2016: Hepatitis C: epidemiology and vaccination perspectives (1) Revue Medicale Suisse 12(502): 156-157
Nau, J.-Y. 2016: Epidemiology of hepatitis C and vaccine perspectives Revue Medicale Suisse 12(503): 234-235
Negro, F. 2011: Chronic hepatitis C: current treatment and perspectives Revue Medicale Suisse 7(279): 212-213
Chow, W.C. 2001: Hepatitis C: issues from the Southeast Asian perspectives Singapore Medical Journal 42(3): 97-98
Bradley, D.W.; Maynard, J.E. 1983: Non-A, non-B hepatitis: research progress and current perspectives Developments in Biological Standardization 54: 463-473
Wang, C-Shan.; Wang, S-Tair.; Chang, T-Tsung.; Yao, W-Jen.; Chou, P. 2002: Smoking and alanine aminotransferase levels in hepatitis C virus infection: implications for prevention of hepatitis C virus progression Archives of Internal Medicine 162(7): 811-815
van Loghem, J.J. 1979: Recommendations concerning anti-HBs in transfusion blood and application of anti-hepatitis B immunoglobulin concentrations in the prevention of hepatitis B Nederlands Tijdschrift Voor Geneeskunde 123(43): 1874-1875
Pongpipat, D.; Suvatte, V.; Assateerawatts, A. 1986: Efficacy of hepatitis-B immunoglobulin and hepatitis-B vaccine in prevention of the HBsAg carrier state in newborn infants of mothers who are chronic carriers of HBsAg and HBeAg Asian Pacific Journal of Allergy and Immunology 4(1): 33-36
Fabrizi, F.; Martin, P.; Lunghi, G.; Ponticelli, C. 2000: Nosocomial transmission of hepatitis C virus infection in hemodialysis patients: clinical perspectives International Journal of Artificial Organs 23(12): 805-816
Wagner, W.H. 1986: Malaria prevention. Chemotherapy and immune prophylaxis. 3. Immune response of infected organism. Perspectives of Malaria prevention Arzneimittel-Forschung 36(3): 409-415
Hille-Rehfeld, A. 2005: Celiac disease--new perspectives for prevention and treatment Medizinische Monatsschrift für Pharmazeuten 28(12): 445-446
Kipshidze, N.; Moses, J.; Shankar, L.R.; Leon, M. 2001: Perspectives on antisense therapy for the prevention of restenosis Current Opinion in Molecular Therapeutics 3(3): 265-277